MILMEGA is a company specializing in designing and manufacturing solid state, high power amplifiers for electromagnetic compatibility (EMC) testing. Headquartered in Ryde on the Isle of Wight in England, MILMEGA mainly provides broadband amplifier products ranging in frequency from 80 MHz to 8 GHz, with power levels from 30W - 1kW.
Founded in 1987, MILMEGA designs and manufactures solid state, high power amplifiers for commercial and government applications. The amplifier products range in frequency from 80 MHz to 8 GHz with power levels to 1 kW.
MILMEGA’s first design was a contract to deliver a narrow-band amplifier to meet the requirements of a medical product used in the treatment of prostate cancer.
In 2004 the company was acquired by its management team in a management buyout (MBO) in part financed by venture capital funding from South East Growth Fund.
Since the MBO the company has invested in new product development in the field of wide bandgap transistor technologies, specifically, silicon carbide transistor (SiC) and gallium nitride transistor (GaN) technologies.
In 2010 the company centralised its operations at the current factory at Ryde, on the Isle of Wight, and in the same year, launched its Chinese language website.
In February 2012, MILMEGA was purchased by Teseq Holding AG. Teseq Holding AG is a developer and provider of instrumentation and systems for EMC emission and immunity testing.
In April 2012 MILMEGA won the Queen's Award for Innovation for their 80 MHz to 1 GHz range of amplifier.
In January 2014, the Teseq Group was purchased my AMETEK Inc. AMETEK is a manufacturer of electronic instruments and electro-mechanical devices.
Today, MILMEGA’s workforce consists of 35 design and production staff.